Extracellular matrix in retinal vascular development and pathological angiogenesis (2016)
Attributed to:
Development of an opticin-based anti-angiogenic therapeutic for the treatment of ocular disease.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Publication URI: http://www.arvo.org/online_planner/
Type: Conference/Paper/Proceeding/Abstract